teaser
This review considers analyses undertaken on the economic impact of healthcare-acquired infections and the pharmacoeconomic impact of new drug therapies, including antibiotics such as linezolid
Dilip Nathwani
MB FRCP DTM&H
↓Article continues below this sponsored advert↓
Explore the latest advances in cardiovascular care delivered by renowned experts from recognised Centres of Excellence and other NHS trusts around the UK. Gain CPD, put your burning questions to the experts, and boost your confidence when it comes to care for your patients.
↑Advertisement↑
Consultant Physician and Honorary Professor
Infection Unit
Ninewells Hospital and Medical School
Dundee
UK
SENTRY antimicrobial programme data for 1997
